Skip to main content
Equibles
FBIO logo

FBIO · Fortress Biotech, Inc. · Documents

Track FBIO — free

Use FBIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research FBIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.99 -0.02 (-1.00%) At close · Nov 12 Q3 2025 earnings call transcript
Rebalance outlook locked
Market Cap
$73.19M
Shares
36.78M
Volume · Nov 12 297.96K Avg daily vol (3M) 315.02K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $63.26M up 9.7% 10-K filed Mar 31, 2026 Quarterly report FY2026 Q2 Revenue $18.72M up 14.0% 10-Q filed Aug 13, 2026 Latest results Financial results 8-K filed Aug 13, 2026 Earnings call Q3 2025 earnings call Held Nov 14, 2025
2026
Oct 1
Current report 8-K Events of Sep 30
Other events

Fortress Biotech, Inc. repaid the remaining $15.0 million under its Oaktree credit facility on September 30, 2026, plus approximately $435,000 in accrued interest and a $150,000 prepayment fee, extinguishing the debt and releasing all liens.

Aug 13
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $18.72M ▲ 14.0% Net loss $468K Diluted EPS -$0.08
May 14
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $16.04M ▲ 22.1% Net income $110.37M Diluted EPS $2.82
Apr 28
Proxy statement DEF 14A Meeting Jun 17, 2026
Proxy statement AI summary on its way
Mar 31
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $63.26M ▲ 9.7% Net income $6.82M Diluted EPS -$0.07
Mar 30
Current report 8-K
Other events AI summary on its way
Jan 13
Current report 8-K
Other events AI summary on its way
2025
Mar 31
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $57.68M ▼ 31.8% Net loss $46M Diluted EPS -$2.69
2024
Showing 1–50 of 160 documents
Key facts CIK 1429260 CUSIP 34960Q307 13F (30d) 44 filings 31 filers Visit website Investor relations